BackgroundThe neuropeptide oxytocin is proposed as a promising therapy for social
dysfunction by modulating amygdala-mediated social-emotional behavior. Although clinical …

Reports on the modulatory role of the neuropeptide oxytocin on social cognition and
behavior have steadily increased over the last two decades, stimulating considerable …

Background Current neuroimaging perspectives on a variety of mental disorders emphasize
dysfunction of the amygdala. The neuropeptide oxytocin (OXT), a key mediator in the …

The neuropeptide oxytocin (OXT) plays an important role in complex socio-affective
behaviours such as affiliation, attachment, stress and anxiety. Previous studies have focused …

The neuropeptide oxytocin plays a role in social cognition and affective processing. The
neural processes underlying these effects are not well understood. Modulation of …

The hypothalamic peptide oxytocin modulates a wide range of social and cognitive functions
in humans and nonhuman primates. As a result, much effort is currently being devoted to …

Oxytocin (OT) is becoming increasingly established as a prosocial neuropeptide in humans
with therapeutic potential in treatment of social, cognitive, and mood disorders. However, the …

The hypothalamic neuropeptide oxytocin (OT) has received increasing attention for its role in
modulating social-emotional processes across species. Previous studies on using intranasal …

Introduction: Oxytocin (OXT) is proposed as a potential therapeutic peptide for social
dysfunction due to its modulatory actions on socioemotional regulation in humans. While the …

Accumulating evidence suggests that intranasal oxytocin (OXT; 24 IU) reduces amygdala
responses to fear-related stimuli in men, while exerting inverse effects in women. However …